MaxLinear, Inc. Announces Financial Conference Participation for the Fourth Quarter 2023

CARLSBAD, Calif.--(BUSINESS WIRE)-- MaxLinear, Inc. (Nasdaq: MXL), a leading provider of RF, analog, digital and mixed-signal integrated circuits, today announced that it will participate in the following financial conferences through January 2024:

• The Stifel 2023 Midwest Growth Conference on November 9, 2023 in Chicago
• The 12th Annual Roth Capital Technology Event on November 15, 2023 in New York
• The UBS Global Technology Conference on November 28, 2023 in Scottsdale. MaxLinear’s presentation is scheduled for 12:35 p.m. PT. A webcast of the session will be available at https://investors.maxlinear.com.
• The Wells Fargo 2023 7th Annual TMT Summit on November 29, 2023 in Rancho Palos Verdes, California. MaxLinear’s presentation is scheduled for 12:45 p.m. PT. A webcast of the session will be available at https://investors.maxlinear.com.
• The 26th Annual Needham Growth Conference on January 18, 2024 in New York. A webcast of MaxLinear’s presentation will be available at https://investors.maxlinear.com.

About MaxLinear, Inc.

MaxLinear, Inc. (Nasdaq: MXL) is a leading provider of radio frequency (RF), analog, digital and mixed-signal integrated circuits for access and connectivity, wired and wireless infrastructure, and industrial and multi-market applications. MaxLinear is headquartered in Carlsbad, California. For more information, please visit www.maxlinear.com.

MaxLinear, the MaxLinear logo, and any other MaxLinear trademarks are all property of MaxLinear, Inc. or one of MaxLinear's subsidiaries in the U.S.A. and other countries. All rights reserved. All third-party marks and logos are trademarks or registered trademarks of their respective holders/owners.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231106359717/en/

MaxLinear, Inc. Investor Relations Contact:
Leslie Green
Tel: 650-312-9060
[email protected]

Source: MaxLinear, Inc.

You May Also Be Interested In

• Longhorn Vaccines and Diagnostics Presents New Data on its Best-In-Class Infectious Disease Vaccine and Antibody Portfolio at ECCMID 2024
• MaxLinear (MXL) Tops Q1 EPS by 1c, provides outlook
• Bragar Eagel & Squire is Investigating Certain Officers and Directors of Caribou, Verrica, and Playstudios on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm